共 37 条
- [2] Predicting Long-Term Effects of Ranibizumab Therapy on the Diabetic Retinopathy Severity Score (DRSS) based on the Short-Term DRSS Improvement in the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
- [4] Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes—Protocol 3 with high dose) Eye, 2015, 29 : 1538 - 1544
- [7] Short-Term Effects of Ranibizumab on Diabetic Retinopathy Severity and Progression OPHTHALMOLOGY RETINA, 2018, 2 (07): : 749 - 751